AusBiotech

AusBiotech is seeking feedback on a recently released issues paper aimed at progressing the implementation of Gene Technology Scheme recommendations.

Life science leaders and investors are assembling in Melbourne for biotech’s biggest week of 2019, with both AusBiotech 2019 and the Australia Biotech Invest & Partnering 2019 conference happening.

After a borad consultation, the TGA has issued a notice outlining how the collection, manufacture and supply of faecal microbiota transplant products are to be regulated in Australia.

The $45 million BioMedTech Horizons programme is inviting expressions of interest (EOIs) from medtech innovators for funds of up to $1 million over a two-year period.

AusBiotech warmly welcomes Dr Peter French as their new Industry Development Manager, NSW - an indication of its continued support of life sciences across Australia. Dr French has strong industry connections and will be a key part of growing the NSW life sciences industry.

Voting for the AusBiotech’s election ballot close on 14 October, which looks to elect a director to the one available position on the Board. Eligible members are urged to have their say and vote through the online voting emailed directly to them.

A review of the Export Market Development Grants scheme and Australian Government financial assistance to SME exporters has been announced by the Minister for Trade, Tourism and Investment, Senator the Hon Simon Birmingham.

Therapeutic Innovation Australia has announced the opening of the latest round of its Pipeline Accelerator scheme, which will focus on support for High Throughput Screening for small molecule drug discovery.

A new report says Victoria’s pharma and medtech sector is booming, with new data released this week showing that Government support has fuelled exceptional export growth.

ANDHealth is seeking input from digital health innovators and companies to identify gaps, challenges and opportunities in digital health commercialisation.

An Australian Biotechnology 2030 Vision (the Vision) – a decadal framework for the industry – was discussed at the AusBiotech CEO Policy Forum in Canberra last week.

AusBiotech is calling for expressions of interest from members to join the AusMedtech 2020 programme committee.